Germany’s ITM, a stalwart in the highly specialized field of radiopharmaceuticals, will soon announce the results from its ...
Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug ...
Novartis sues HHS over rejection of a proposed 340B rebate model, arguing it enhances transparency and compliance while ...
The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s ...
Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program.
3don MSN
Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...
The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
Speaking to CNBC-TV18 at the World Economic Forum in Davos, Narasimhan discussed the company's operations in India, where ...
In a pivotal decision Friday, the Federal Circuit revived a key patent for Novartis' blockbuster heart failure drug Entresto, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results